The ICHOM team is pleased to announce a new Strategic Alliance with the Specialist Diabetes Treatment & Research Centre (Imperial College London Diabetes Centre).
We are delighted to partner with one of Abu Dhabi’s state-of-the-art diabetes clinics, which is at the very forefront of value-based health care thinking. The Centre’s Strategic Alliance with ICHOM represents both organizations’ commitment to outcomes measurement as a means of driving value in health care, and the development of a Standard Set of outcomes that matter most to people with Type-2 diabetes.
Dr Mazen Al Dahmani, Deputy Chief Executive Officer at Imperial College London Diabetes Centre, Abu Dhabi said, “since the Imperial College London partnership with our Centre in Abu Dhabi in 2006, we have enabled greater clinical collaboration, knowledge transfer and clinical capabilities here in the UAE. As a Centre, we understand that cross collaboration is key if we are to tackle diabetes here in the UAE as well as globally.” ICHOM’s President, Dr Christina Akerman said, “The Imperial College London Diabetes Centre’s work with ICHOM represents both organizations’ long-term commitment to driving value, not just locally in Abu Dhabi, but across health systems globally.”